- Home
- BLNK vs MGTX Comparison
BLNK vs MGTX Comparison
Compare BLNK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLNK | MGTX |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.3M | 665.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BLNK | MGTX |
|---|---|---|
| Price | $0.71 | $8.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $2.13 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 8.1M | 499.2K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,631,000.00 | $27,417,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.87 | $619.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 96.83 |
| 52 Week Low | $0.63 | $4.55 |
| 52 Week High | $2.65 | $9.73 |
Technical Indicators
Market Signals| Indicator | BLNK | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.77 | 49.79 |
| Support Level | $0.63 | $7.66 |
| Resistance Level | $0.85 | $8.40 |
| Average True Range (ATR) | 0.06 | 0.50 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 33.72 | 27.45 |
Price Performance
Historical ComparisonAbout BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.